REDMOND, Wash.--(BUSINESS WIRE)--Medicare beneficiaries in 10 Midwestern and Northeastern states will soon have reimbursed access to the Transoral Incisionless Fundoplication (TIF®) procedure ...
The transoral incisionless fundoplication, or TIF, procedure is a relatively mild surgical technique. It was developed to treat a particular medical condition called gastroesophageal reflux disease ...
REDMOND, Wash.--(BUSINESS WIRE)--EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), today announced the presentation of data from the ...
Transoral fundoplication is an effective treatment for patients with gastroesophageal reflux disease, especially for patients with persistent regurgitation despite proton pump inhibitor therapy, ...
EndoGastric Solutions will present new data on the company’s Transoral Incisionless Fundoplication procedure for the treatment of gastroesophageal reflux disease at the Digestive Disease Week 2016 ...
A new white paper by the American Foregut Society (AFS) summarizes the published outcome data for Transoral Incisionless Fundoplication 2.0 (TIF 2.0) and Concomitant Transoral Incisionless ...
Mansfield, TX, May 21, 2024 (GLOBE NEWSWIRE) -- Dr. Moustafa Youssef, a distinguished gastroenterologist based in Mansfield, Texas, has penned a compelling article shedding light on the groundbreaking ...
Portsmouth Regional Hospital is now offering a new treatment for chronic acid reflux. The procedure, transoral incisionless fundoplication (TIF), creates a barrier at the top of the stomach to prevent ...
Two surgeons from Wisconsin are utilizing transoral incisionless fundoplication to help relieve patients of gastroesophageal reflux disease, according to a Post Crescent news report. Kevin Wasco, MD, ...
EndoGastric Solutions (EGS) announces that Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute and the most prominent journal in the field of ...
PHILADELPHIA — Endoscopic fundoplication is better for treating regurgitation than a maximum-dose proton pump inhibitor (PPI) in patients with gastroesophageal reflux disease, results from the RESPECT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback